ACS Discovery Pillar work was noted in publications and recognitions.
Dr. Knudsen quoted in Fortune
Multi-cancer early detection tests, known as MCEDs, is a concept that has promise, CEO Dr. Karen Knudsen discussed in a recent Fortune story. “The technology is advancing truly at a rapid pace,” she said. “I think all of us in the oncology world think that the next frontier is liquid biopsy” – another term for MCED.
ACS scientists to present research at AACR Annual Meeting
ACS researchers are headed to Orlando, FL, for the annual meeting of the American Association of Cancer Research (AACR). The meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine.
ACS members will attend lectures, symposiums, and educational sessions at the meeting. They will also present important cancer research studies including these highlighted abstracts:
Dr. Hyuna Sung
- Survival of most commonly diagnosed second primary cancers among adult cancer survivors (April 17, at 1:30 p.m. ET)
- Survival among adults diagnosed with secondary acute myeloid leukemia (April 18, at 9 a.m. ET)
Dr. Ying Wang
- Postdiagnosis adherence to American Cancer Society cancer prevention guidelines and mortality among survivors of obesity-related cancers (April 19, at 9 a.m. ET)
Other ACS researchers contributing to these studies at this year’s annual meeting include Dr. Ahmedin Jemal, Rebecca Siegel, Dr. Farhad Islami, Christina Newton, Marjorie McCullough, Dr. Lauren Teras, Dr. Erika Rees-Punia, Dr. Caroline Um, and Dr. Alpa Patel.
Like and share this recent tweet about the news.
